Drug Search Results
More Filters [+]

Dinoprost

Alternative Names: dinoprost, prostaglandin f2alpha
Latest Update: 2012-09-21
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PGD2 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Austria | Bangladesh | Canada | Czech | Greece | Hungary | India | Ireland | Malaysia | New Zealand | Pakistan | Poland | Portugal | Russia | South Africa | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dinoprost

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title